THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA

被引：0

作者：

Barratt, Jonathan ^{[1
]}

Tumlin, James A. ^{[2
]}

Suzuki, Yusuke ^{[3
]}

Kao, Amy ^{[4
]}

Aydemir, Aida ^{[5
]}

Zima, Yulia ^{[5
]}

Appel, Gerald ^{[6
]}

机构：

[1] Leicester Gen Hosp, John Walls Renal Unit, Leicester, Leics, England

[2] Emory Univ, Sch Med, GA Nephrol, Atlanta, GA USA

[3] Juntendo Univ, Fac Med, Dept Nephrol, Tokyo, Japan

[4] EMD Serono Res & Dev Inst Inc, Immunol, Billerica, MA USA

[5] EMD Serono Res & Dev Inst Inc, Billerica, MA USA

[6] Columbia Univ, Med Ctr, Div Nephrol & Hypertens, New York, NY USA

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

MO039

引用

页码：139 / 139

页数：1

共 50 条

[21] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (THE ALIGN STUDY)
Heerspink, Hiddo Lambers
Kohan, Donald
Lafayette, Richard
Levin, Adeera
Zhang, Hong
Glicklich, Aland
Camargo, Marianne
King, Andrew
Barratt, Jonathan
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 194 - 194
[22] Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Haering, Hans-Ulrich
Merker, Ludwig
Seewaldt-Becker, Elke
Weimer, Marc
Meinicke, Thomas
Broedl, Uli C.
Woerle, Hans J.
[J]. DIABETES CARE, 2014, 37 (06) : 1650 - 1659
[23] Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study
Simpson, Richard W.
Nicholson, Geoffrey C.
Proietto, Joseph
Sarah, Alana
Sanders, Kerrie M.
Phillips, Gabrielle
Chambers, Jo
MacGinley, Rob
Orford, Neil
Walder, Ken
Krippner, Guy
Skoff, Kathy
Wacher, Vincent J.
[J]. DIABETES CARE, 2014, 37 (11) : 3121 - 3123
[24] Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
Zhang, Hong
Rizk, Dana, V
Perkovic, Vlado
Maes, Bart
Kashihara, Naoki
Rovin, Brad
Trimarchi, Hernan
Sprangers, Ben
Meier, Matthias
Kollins, Dmitrij
Papachristofi, Olympia
Milojevic, Julie
Junge, Guido
Nidamarthy, Prasanna Kumar
Charney, Alan
Barratt, Jonathan
[J]. KIDNEY INTERNATIONAL, 2024, 105 (01) : 189 - 199
[25] Vitamin E does not reduce symptoms of rheumatoid arthritis: A 24-week randomized, double-blind, placebo-controlled study.
Boileau, N
Blumberg, J
Dallal, GE
Golly, I
Roubenoff, R
[J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S179 - S179
[26] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
Papp, K
Mease, P
Garovoy, M
Zhang, D
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
[27] Treatment of severe Alzheimer's disease with donepezil: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S
Li, HL
McRae, T
Richardson, S
[J]. NEUROLOGY, 2006, 66 (05) : A347 - A347
[28] Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S.
Li, H.
McRae, T.
Richardson, S.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 69 - 69
[29] Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study
Chan, JCM
Mahan, JD
Trachtman, H
Scheinman, J
Flynn, JT
Alon, US
Lande, MB
Weiss, RA
Norkus, EP
[J]. PEDIATRIC NEPHROLOGY, 2003, 18 (10) : 1015 - 1019
[30] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
Goodman, A. D.
Rossman, H.
Bar-Or, A.
Miller, A.
Miller, D. H.
Schmierer, K.
Lublin, F.
Khan, O.
Bormann, N. M.
Yang, M.
Panzara, M. A.
Sandrock, A. W.
[J]. NEUROLOGY, 2009, 72 (09) : 806 - 812

← 1 2 3 4 5 →